Ashwani Verma
Stock Analyst at UBS
(0)
# 3325
Out of 5,218 analysts
60
Total ratings
51.61%
Success rate
3.56%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Arcellx | Maintains: Strong Buy | 106 114 | 83.86 | 35.94% | 2 | Dec 10, 2024 | |
Exelixis | Initiates Coverage On: Neutral | 30 | 35.01 | -14.31% | 1 | Sep 19, 2024 | |
Harmony Biosciences | Initiates Coverage On: Buy | 56 | 32.38 | 72.95% | 1 | Sep 10, 2024 | |
Teva Pharmaceutical ... | Maintains: Strong Buy | 24 26 | 16.48 | 57.77% | 6 | Sep 3, 2024 | |
Coherus BioSciences | Downgrades: Neutral | 4 2 | 1.61 | -6.83% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 54 | 38.47 | 40.37% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 83 79 | 83.02 | -4.84% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 23 | 17.3 | 32.95% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 107 105 | 90.01 | 16.65% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 300 370 | 361.37 | 2.39% | 3 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 117 113 | 123 | -8.13% | 5 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | 24.84 | 12.72% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 174 193 | 126.68 | 52.35% | 4 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 76 81 | 35.19 | 130.18% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 25 25 | 30.46 | -17.93% | 2 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 21 | 10.4 | 101.92% | 1 | Feb 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 61 92 | 48.66 | 89.07% | 4 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 7 | 106.75 | -93.44% | 1 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 209 | n/a | n/a | 2 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 12.63 | -4.99% | 2 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 1.65 | 809.09% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 137 71 | n/a | n/a | 3 | Aug 4, 2022 |